March 28, 2019 Price forecast | 2 weeks: -1.22% | 1 month: -0.86% | 3 months: 1.41%

SLDB stock forecast

Our latest prediction for Solid Biosciences, Inc.'s stock price was made on the March 28, 2019 when the stock price was at 9.59$.

In the short term (2weeks), SLDB's stock price should underperform the market by -1.22%. During that period the price should oscillate between -11.74% and +21.17%.

In the medium term (3months), SLDB's stock price should outperform the market by 1.41%. During that period the price should oscillate between -24.68% and +52.69%.

Create a solid portfolio with SLDB

Add SLDB to your portfolio and optimize it!

About Solid Biosciences, Inc.

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.25$ per share.

The book value per share is 4.58$

Solid Biosciences, Inc. website

Three months stock forecastMarch 28, 2019


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -76M - -75M -2.25 - - 35M 4.58 -70M -8M -78M